Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XOMA | XOMA ROYALTY CORP | $312.30M | $47.11M | $26.75M | $16.60M | $0.81 | 118.02% | 84.11% | N/A | N/A | |||
| AKA | AKA BRANDS HOLDING CORP | $126.08M | $595.28M | $18.34M | -$26.29M | -$2.46 | 5.44% | N/A | N/A | N/A | |||
| DMAC | DIAMEDICA THERAPEUTICS INC | $489.01M | $0.00 | -$31.82M | -$31.97M | -$0.71 | N/A | N/A | N/A | N/A | |||
| NTGR | NETGEAR INC | $697.86M | $699.57M | -$18.83M | -$26.13M | -$0.90 | 2.88% | -9.32% | N/A | N/A | |||
| CHYM | CHIME FINANCIAL INC | $9.81B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| ENTA | ENANTA PHARMACEUTICALS INC | $425.15M | $65.32M | -$71.28M | -$81.89M | -$3.84 | -3.42% | -11.81% | N/A | N/A | 2026-02-09 | ||
| CGTX | COGNITION THERAPEUTICS INC | $149.18M | $0.00 | -$27.74M | -$27.99M | -$0.48 | N/A | N/A | N/A | N/A | |||
| OTLY | OATLY GROUP AB | $351.07M | $843.00M | -$41.51M | -$224.83M | -$7.40 | 3.63% | N/A | N/A | N/A | |||
| CRVO | CERVOMED INC | $78.19M | $6.16M | -$25.58M | -$25.58M | -$2.90 | -38.81% | N/A | N/A | N/A | |||
| RZLT | REZOLUTE INC | $166.91M | $0.00 | -$76.61M | -$77.18M | -$0.93 | N/A | N/A | N/A | N/A | |||
| BSVN | BANK7 CORP | $416.80M | $95.71M | $58.40M | $43.39M | $4.62 | 11.45% | 17.05% | 20.00% | 18.59% | 2026-02-04 | ||
| KYMR | KYMERA THERAPEUTICS INC | $6.45B | $43.73M | -$286.52M | -$295.12M | -$3.60 | -50.05% | 13.63% | N/A | N/A | |||
| PHR | PHREESIA INC | $979.66M | $463.21M | $25.66M | -$5.38M | -$0.10 | 14.33% | 27.09% | N/A | N/A | |||
| SMWB | SIMILARWEB LTD | $645.40M | $275.43M | -$12.10M | -$30.86M | -$0.36 | 14.25% | N/A | N/A | N/A | 2026-02-10 | ||
| CYBN | CYBIN INC | $153.86M | $0.00 | -$70.85M | -$71.04M | -$3.20 | N/A | N/A | N/A | N/A | |||
| ICHR | ICHOR HOLDINGS LTD | $612.73M | $957.34M | $3.11M | -$40.76M | -$1.20 | 16.86% | 2.20% | N/A | N/A | 2026-02-03 | ||
| PRQR | PROQR THERAPEUTICS NV | $250.97M | $18.69M | -$44.45M | -$49.50M | -$0.48 | -20.16% | 10.57% | N/A | N/A | |||
| TBPH | THERAVANCE BIOPHARMA INC | $920.72M | $80.33M | $55.37M | $29.34M | $0.58 | 27.12% | -0.56% | N/A | N/A | |||
| SGMT | SAGIMET BIOSCIENCES INC | $202.61M | $0.00 | -$57.52M | -$57.67M | -$1.78 | N/A | N/A | N/A | N/A | |||
| ELVN | ENLIVEN THERAPEUTICS INC | $1.00B | $0.00 | -$96.57M | -$97.21M | -$1.84 | N/A | N/A | N/A | N/A | |||
| CTNM | CONTINEUM THERAPEUTICS INC | $339.39M | $0.00 | -$58.23M | -$59.39M | -$2.26 | N/A | N/A | N/A | N/A | |||
| XNCR | XENCOR INC | $1.18B | $150.13M | -$84.93M | -$130.82M | -$1.73 | 38.16% | 12.22% | N/A | N/A | |||
| PSN | PARSONS CORP | $6.74B | $6.49B | $667.30M | $386.84M | $3.63 | -0.24% | 10.22% | 71.23% | 33.07% | |||
| ATR | APTARGROUP INC | $7.97B | $3.66B | $841.57M | $419.39M | $6.35 | 2.50% | 5.13% | 25.00% | 14.26% | 2026-02-12 | ||
| SYRE | SPYRE THERAPEUTICS INC | $2.61B | $0.00 | -$148.98M | -$148.97M | -$2.03 | N/A | N/A | N/A | N/A | |||
| ORIC | ORIC PHARMACEUTICALS INC | $913.51M | $0.00 | -$134.07M | -$135.27M | -$1.73 | N/A | N/A | N/A | N/A | |||
| FBRX | FORTE BIOSCIENCES INC | $267.70M | $0.00 | -$51.69M | -$51.74M | -$0.14 | N/A | N/A | N/A | N/A | |||
| PVLA | PALVELLA THERAPEUTICS INC | $1.17B | -$53.00k | -$27.96M | -$35.07M | -$1.62 | N/A | N/A | N/A | N/A | |||
| RIOT | RIOT PLATFORMS INC | $5.69B | $637.16M | $538.59M | $164.00M | $0.55 | 103.62% | 140.07% | 161.90% | N/A | |||
| IBIO | IBIO INC | $43.63M | $500.00k | -$18.78M | -$20.11M | -$1.39 | 185.71% | -23.75% | N/A | N/A | |||
| TNGX | TANGO THERAPEUTICS INC | $1.26B | $66.50M | -$94.03M | -$100.52M | -$0.91 | 53.28% | N/A | N/A | N/A | |||
| TVRD | TVARDI THERAPEUTICS INC | $41.37M | $4.02M | -$8.73M | -$13.95M | -$8.50 | -21.70% | -31.91% | N/A | N/A | |||
| IDYA | IDEAYA BIOSCIENCES INC | $2.98B | $214.83M | -$156.70M | -$160.74M | -$1.90 | 5,377.66% | 88.75% | N/A | N/A | |||
| BITF | BITFARMS LTD | $1.54B | $270.06M | -$27.07M | -$130.32M | -$0.23 | 63.49% | N/A | N/A | N/A | |||
| NAVN | NAVAN INC | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2025-12-15 | ||
| CCCC | C4 THERAPEUTICS INC | $239.38M | $30.11M | -$110.30M | -$119.08M | -$1.67 | -10.57% | -1.90% | N/A | N/A | |||
| TYRA | TYRA BIOSCIENCES INC | $1.21B | $0.00 | -$111.13M | -$111.68M | -$1.87 | N/A | N/A | N/A | N/A | |||
| BLLN | BILLIONTOONE INC | $4.67B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| OCUL | OCULAR THERAPEUTIX INC | $3.10B | $55.78M | -$233.54M | -$249.67M | -$1.43 | -9.21% | 35.28% | N/A | N/A | |||
| CLFD | CLEARFIELD INC | $410.19M | $150.13M | $428.00k | -$8.05M | -$0.58 | 19.56% | 10.03% | N/A | N/A | 2026-01-22 | ||
| TRVI | TREVI THERAPEUTICS INC | $1.64B | $0.00 | -$45.74M | -$45.86M | -$0.37 | N/A | N/A | N/A | N/A | |||
| NEXN | NEXXEN INTERNATIONAL LTD | $198.73M | $376.35M | $112.03M | $39.36M | $1.34 | 7.80% | N/A | 3,250.00% | N/A | |||
| IMTX | IMMATICS NV | $1.22B | $98.56M | -$124.76M | -$134.75M | -$1.05 | -22.30% | 26.18% | N/A | N/A | |||
| CARL | CARLSMED INC | $344.38M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| TIGR | UP FINTECH HOLDING LTD | $1.64B | $489.54M | N/A | $153.72M | $0.89 | 76.50% | 36.33% | 353.85% | 53.16% | |||
| SLDB | SOLID BIOSCIENCES INC | $457.33M | $0.00 | -$162.61M | -$167.14M | -$2.51 | N/A | N/A | N/A | N/A | |||
| OMDA | OMADA HEALTH INC | $874.41M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| CGEM | CULLINAN THERAPEUTICS INC | $704.19M | $0.00 | -$216.39M | -$219.46M | -$3.06 | N/A | N/A | N/A | N/A | |||
| ALEC | ALECTOR INC | $162.64M | $69.05M | -$98.21M | -$107.74M | -$1.06 | 12.26% | 25.42% | N/A | N/A | |||
| CMPX | COMPASS THERAPEUTICS INC | $917.77M | $0.00 | -$64.35M | -$65.81M | -$0.45 | -100.00% | N/A | N/A | N/A | |||
| CATX | PERSPECTIVE THERAPEUTICS INC | $198.48M | $1.08M | -$104.81M | -$105.80M | -$1.50 | -30.96% | -35.66% | N/A | N/A | |||
| VTYX | VENTYX BIOSCIENCES INC | $584.43M | $0.00 | -$105.29M | -$106.61M | -$1.50 | N/A | N/A | N/A | N/A | |||
| AIRG | AIRGAIN INC | $48.43M | $54.74M | -$2.23M | -$5.95M | -$0.50 | -1.53% | 2.37% | N/A | N/A | |||
| EYPT | EYEPOINT PHARMACEUTICALS INC | $1.32B | $42.34M | -$203.48M | -$205.75M | -$3.00 | -7.38% | 3.33% | N/A | N/A | |||
| OLMA | OLEMA PHARMACEUTICALS INC | $2.27B | $0.00 | -$148.38M | -$149.96M | -$1.76 | N/A | N/A | N/A | N/A | |||
| LXEO | LEXEO THERAPEUTICS INC | $713.09M | $0.00 | -$102.80M | -$104.97M | -$2.70 | N/A | N/A | N/A | N/A | 2025-12-15 | ||
| T | AT&T INC | $174.26B | $124.48B | $54.46B | $22.17B | $3.08 | 1.98% | -6.36% | 150.41% | 15.17% | 2026-01-28 | ||
| NRIX | NURIX THERAPEUTICS INC | $1.47B | $83.69M | -$225.49M | -$244.79M | -$2.97 | 48.32% | 45.14% | N/A | N/A | |||
| NTSK | NETSKOPE INC | $8.15B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.